Cargando…

CLL Exosomes Modulate the Transcriptome and Behaviour of Recipient Stromal Cells and Are Selectively Enriched in miR-202-3p

Bi-directional communication with the microenvironment is essential for homing and survival of cancer cells with implications for disease biology and behaviour. In chronic lymphocytic leukemia (CLL), the role of the microenvironment on malignant cell behaviour is well described. However, how CLL cel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Farahani, Mosavar, Rubbi, Carlos, Liu, Luning, Slupsky, Joseph R., Kalakonda, Nagesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4625016/ https://www.ncbi.nlm.nih.gov/pubmed/26509439 http://dx.doi.org/10.1371/journal.pone.0141429

Ejemplares similares

Kinobead Profiling Reveals Reprogramming of BCR Signaling in Response to Therapy within Primary CLL Cells
por: Linley, Adam J., et al.
Publicado: (2021)

Exosomal miR-202 derived from leukorrhea as a potential biomarker for endometriosis
por: Zheng, Li, et al.
Publicado: (2023)

Role of stromal cell-mediated Notch signaling in CLL resistance to chemotherapy
por: Kamdje, A H Nwabo, et al.
Publicado: (2012)

Is miR-29 an oncogene or tumor suppressor in CLL?
por: Pekarsky, Yuri, et al.
Publicado: (2010)

Role of Chronic Lymphocytic Leukemia (CLL)-Derived Exosomes in Tumor Progression and Survival
por: Nisticò, Nancy, et al.
Publicado: (2020)

COVID‐19 outcomes in haematopoietic cell transplant recipients: A systematic review and meta‐analysis
por: Lim, Yeong Jer, et al.
Publicado: (2022)

MiR-202 controls female fecundity by regulating medaka oogenesis
por: Gay, Stéphanie, et al.
Publicado: (2018)

The interferon-inducible protein p202 promotes osteogenesis in mouse bone marrow stromal cells
por: Zhang, Linlin, et al.
Publicado: (2018)

Localization and in silico‐based functional analysis of miR‐202 in bull testis
por: Mohammed, Bushra T., et al.
Publicado: (2022)

Lenalidomide, dexamethasone and alemtuzumab or ofatumumab in high-risk chronic lymphocytic leukemia: final results of the NCRI CLL210 trial
por: Pettitt, Andrew R., et al.
Publicado: (2020)

Transcriptional mechanism of vascular endothelial growth factor-induced expression of protein kinase CβII in chronic lymphocytic leukaemia cells
por: Al-Sanabra, Ola, et al.
Publicado: (2017)

202. The Impact and Safety of Discontinuing Routine Surveillance Blood Culture Monitoring in Allogeneic Hematopoietic Cell Transplant Recipients
por: Garner, Will, et al.
Publicado: (2021)

CLL-033 Is COVID-19 Infection a Trigger for Progression of CLL?
por: Popov, Viola, et al.
Publicado: (2022)

miR-202 Suppresses Cell Proliferation by Targeting FOXR2 in Endometrial Adenocarcinoma
por: Deng, Xinchao, et al.
Publicado: (2017)

RNA-Seq profiling of deregulated miRs in CLL and their impact on clinical outcome
por: Kaur, Gurvinder, et al.
Publicado: (2020)

Memorandum 202: plans for 1985
por: Garreta, D, et al.
Publicado: (1984)

Abstract - SUA202 (Pediatric)
Publicado: (2020)

Abstract - SUA202 (Transplant)
Publicado: (2020)

Abstract - SUA202 (Endourology)
Publicado: (2020)

Abstract - SUA202 (Reconstructive)
Publicado: (2020)

Abstract - SUA202 (Oncology)
Publicado: (2020)

Investigating the Targets of MIR-15a and MIR-16-1 in Patients with Chronic Lymphocytic Leukemia (CLL)
por: Hanlon, Katy, et al.
Publicado: (2009)

Enrichment of BTK Leu528Trp mutations in patients with CLL on zanubrutinib: potential for pirtobrutinib cross-resistance
por: Blombery, Piers, et al.
Publicado: (2022)

Leptomeningeal involvement in CLL
por: Chantepie, Sylvain P., et al.
Publicado: (2014)

Overexpression of mir-135b and mir-210 in mesenchymal stromal cells for the enrichment of extracellular vesicles with angiogenic factors
por: Vieira, Juliana Maíra Freitas, et al.
Publicado: (2022)

Not all lymphoid aggregates in chronic lymphocytic leukemia (CLL) patients are due to CLL!
por: Mahapatra, Lily, et al.
Publicado: (2021)

Poster: CLL-033 Is COVID-19 Infection a Trigger for Progression of CLL?
por: Popov, Viola, et al.
Publicado: (2022)

CLL-461 Humoral Response to COVID-19 Vaccine: A Challenge in CLL
por: Capasso, Antonella, et al.
Publicado: (2022)

CLL-IPI applied in Binet A CLL: a nationwide cohort study
por: Rotbain, Emelie C., et al.
Publicado: (2022)

Diagnostic Value of Circulating miR-202 in Early-Stage Breast Cancer in South Korea
por: Kim, Jungho, et al.
Publicado: (2020)

miR-202 functions as a tumor suppressor in hepatocellular carcinoma by targeting HK2
por: Wang, Jiangang, et al.
Publicado: (2020)

miR-202 Suppresses Hepatocellular Carcinoma Progression via Downregulating BCL2 Expression
por: Zhuang, Donghai, et al.
Publicado: (2020)

MiR-202-3p determines embryo viability during mid-blastula transition
por: Hu, Ruiqin, et al.
Publicado: (2022)

Quadrupoles type IX and X: Drawings 202-010 LM 1 and 202-013 LM 1
por: Boltezar, E
Publicado: (1974)

Региональная целевая программа «Профилактика йододефицитных заболеваний на 202Х–202Х годы» (Проект)
por: Трошина, Е. А., et al.
Publicado: (2022)

Lck is a relevant target in chronic lymphocytic leukaemia cells whose expression variance is unrelated to disease outcome
por: Till, Kathleen J., et al.
Publicado: (2017)

Poster: CLL-461 Humoral Response to COVID-19 Vaccine: A Challenge in CLL
por: Capasso, Antonella, et al.
Publicado: (2022)

Loss of Dnmt3a induces CLL and PTCL with distinct methylomes and transcriptomes in mice
por: Haney, Staci L., et al.
Publicado: (2016)

Simvastatin and downstream inhibitors circumvent constitutive and stromal cell-induced resistance to doxorubicin in IGHV unmutated CLL cells
por: Rigoni, Micol, et al.
Publicado: (2015)

Status report of PS 202 (JETSET)
por: CERN. Geneva. SPS-LEAR Experiments Committee
Publicado: (1992)

Cannot write session to /tmp/vufind_sessions/sess_nvlun32l8ilkseu121qo2umteb